AAIC 2025 Abstract

Understanding the burden experienced by patients with mild cognitive impairment due to Alzheimer's disease and dementia due to Alzheimer's disease at different stages of disease severity in a real‐world setting

Study in peoplePopulations

Abstract

Background: People with Alzheimer's Disease (AD) inevitably progress from preclinical stage, to experiencing mild cognitive impairment (MCI) to dementia. Our aim was to characterise the burden experienced by patients, delineated by disease severity.

The paper

Novo Nordisk (India); Adelphi Group (United Kingdom)

AAIC 2025 Abstract, 24 Dec 2025, CC BY

Presented at AAIC 2025

doi.org/10.1002/alz70858_097342